194 related articles for article (PubMed ID: 31993894)
61. Competing risk analyses of overall survival and cancer-specific survival in patients with combined hepatocellular cholangiocarcinoma after surgery.
He C; Zhang Y; Cai Z; Lin X
BMC Cancer; 2019 Feb; 19(1):178. PubMed ID: 30813928
[TBL] [Abstract][Full Text] [Related]
62. Development and validation of a novel prognostic model for long-term overall survival in liposarcoma patients: a population-based study.
Cao S; Li J; Yang K; Zhang J; Xu J; Feng C; Li H
J Int Med Res; 2020 Dec; 48(12):300060520975882. PubMed ID: 33296604
[TBL] [Abstract][Full Text] [Related]
63. A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Survival of Patients with Initially Diagnosed Metastatic Esophageal Cancer: A SEER-Based Study.
Tang X; Zhou X; Li Y; Tian X; Wang Y; Huang M; Ren L; Zhou L; Ding Z; Zhu J; Xu Y; Peng F; Wang J; Lu Y; Gong Y
Ann Surg Oncol; 2019 Feb; 26(2):321-328. PubMed ID: 30357578
[TBL] [Abstract][Full Text] [Related]
64. Development and validation of a prognostic nomogram for early-onset colon cancer.
Yu C; Zhang Y
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31142625
[TBL] [Abstract][Full Text] [Related]
65. Construction and Validation of Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Nonmetastatic Inflammatory Breast Cancer Patients Receiving Tri-Modality Therapy: A Population-Based Study.
Huang Q; Xu TY; Wu ZY
Med Sci Monit; 2019 Dec; 25():9167-9178. PubMed ID: 31789307
[TBL] [Abstract][Full Text] [Related]
66. Development and external validation of prognostic nomograms in hepatocellular carcinoma patients: a population based study.
Xiao Z; Yan Y; Zhou Q; Liu H; Huang P; Zhou Q; Lai C; Zhang J; Wang J; Mao K
Cancer Manag Res; 2019; 11():2691-2708. PubMed ID: 31118768
[No Abstract] [Full Text] [Related]
67. Nomogram predicting long-term overall and cancer-specific survival of patients with buccal mucosa cancer.
Wang F; Wen J; Cao S; Yang X; Yang Z; Li H; Meng H; Thieringer FM; Wei J
BMC Oral Health; 2022 Apr; 22(1):138. PubMed ID: 35459139
[TBL] [Abstract][Full Text] [Related]
68. Prognostic nomogram for patients with lung metastatic renal cell carcinoma: a SEER-based study.
Mao W; Fu Z; Wang K; Wu J; Xu B; Chen M
Ann Palliat Med; 2021 Mar; 10(3):2791-2804. PubMed ID: 33549017
[TBL] [Abstract][Full Text] [Related]
69. Development and validation of nomograms for prediction of overall survival and cancer-specific survival of patients with Stage IV colorectal cancer.
Zhang J; Gong Z; Gong Y; Guo W
Jpn J Clin Oncol; 2019 May; 49(5):438-446. PubMed ID: 30924498
[TBL] [Abstract][Full Text] [Related]
70. Comparison of nomogram for Primary Nonfunctional Pancreatic Neuroendocrine Tumors based on the 7th vs 8th edition of the AJCC cancer staging manual.
Heng X; Chen B; Zhao K; Li J; Wu W; Peng Y; Zhong R
PLoS One; 2023; 18(4):e0284930. PubMed ID: 37093837
[TBL] [Abstract][Full Text] [Related]
71. Development and validation of a nomogram containing the prognostic determinants of chondrosarcoma based on the Surveillance, Epidemiology, and End Results database.
Zhang J; Pan Z; Zhao F; Feng X; Huang Y; Hu C; Li Y; Lyu J
Int J Clin Oncol; 2019 Nov; 24(11):1459-1467. PubMed ID: 31243629
[TBL] [Abstract][Full Text] [Related]
72. A Nomogram and a Risk Classification System Predicting the Cancer-Specific Survival of Patients With Initially-Diagnosed Osseous Spinal and Pelvic Tumors.
Zhou Q; Li AB; Lin ZQ; Zhang HZ
Spine (Phila Pa 1976); 2020 Jun; 45(12):E713-E720. PubMed ID: 32039945
[TBL] [Abstract][Full Text] [Related]
73. Development and validation of nomograms predicting postoperative survival in patients with chromophobe renal cell carcinoma.
Li S; Zhu J; He Z; Ashok R; Xue N; Liu Z; Ding L; Zhu H
Front Oncol; 2022; 12():982833. PubMed ID: 36452499
[TBL] [Abstract][Full Text] [Related]
74. Development and Validation of Nomograms Predicting the 5- and 8-Year Overall and Cancer-Specific Survival of Bladder Cancer Patients Based on SEER Program.
Wen P; Wen J; Huang X; Wang F
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835849
[TBL] [Abstract][Full Text] [Related]
75. Construction and validation of the prognostic model for patients with neuroendocrine cervical carcinoma: a competing risk nomogram analysis.
Jiang AG; Cai X
BMC Cancer; 2022 Jan; 22(1):4. PubMed ID: 34980030
[TBL] [Abstract][Full Text] [Related]
76. Nomograms for predicting overall survival and cancer-specific survival of chondroblastic osteosarcoma patients.
Gao Z; Zhou S; Song H; Wang Y; He X
J Surg Oncol; 2020 Dec; 122(8):1676-1684. PubMed ID: 32862456
[TBL] [Abstract][Full Text] [Related]
77. Nomogram for predicting the survival of gastric adenocarcinoma patients who receive surgery and chemotherapy.
Wang CY; Yang J; Zi H; Zheng ZL; Li BH; Wang Y; Ge Z; Jian GX; Lyu J; Li XD; Ren XQ
BMC Cancer; 2020 Jan; 20(1):10. PubMed ID: 31906882
[TBL] [Abstract][Full Text] [Related]
78. Development and validation of a nomogram for predicting survival of pulmonary invasive mucinous adenocarcinoma based on surveillance, epidemiology, and end results (SEER) database.
Wang Y; Liu J; Huang C; Zeng Y; Liu Y; Du J
BMC Cancer; 2021 Feb; 21(1):148. PubMed ID: 33568091
[TBL] [Abstract][Full Text] [Related]
79. Development and validation of prognostic nomograms in patients with adrenocortical carcinoma: a population-based study.
Zhang H; Naji Y; Yan M; Lian W; Xie M; Dai Y
Int Urol Nephrol; 2020 Jun; 52(6):1057-1071. PubMed ID: 32072388
[TBL] [Abstract][Full Text] [Related]
80. A Nomogram for Predicting Cancer-Specific Survival of Patients with Gastrointestinal Stromal Tumors.
Liu M; Song C; Zhang P; Fang Y; Han X; Li J; Wu W; Chen G; Sun J
Med Sci Monit; 2020 May; 26():e922378. PubMed ID: 32449506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
